UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit

Rosen Law Firm issued a solicitation reminding UNCY purchasers (Dec 29, 2025 - Jun 29, 2026) of the November 2, 2026 lead plaintiff deadline in a previously filed securities fraud class action. The suit alleges Unicycive failed to disclose it had not audited its third-party manufacturing vendor's FDA compliance, creating risk of delayed approval of oxylanthanum carbonate.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.